Device Trial Radar · NCT07232030
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,500
Planned (sponsor's estimate)
Start
Apr 24, 2026
Primary completion
Jan 2033
Study completion Jan 2033
Sponsor
- Lead sponsor
- CVRx, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 18, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of BENEFIT-HF is to demonstrate the safety and effectiveness of Baroreflex Activation Therapy (BAT) with the Barostim System in participants with heart failure, defined as NYHA Functional Class II or III, LVEF \< 50% and NT-proBNP \< 5,000 pg/mL despite being treated with Guideline-Directed Medical Therapies (medications and devices). It includes demonstration that treatment with the Barostim System, relative to usual care medical management, reduces the rate of all-cause mortality and Heart Failure Morbidity (Cardiac Transplant, Durable LVAD, or Worsening Heart Failure Events).
Conditions
- Heart Failure
- Heart Failure NYHA Class II
- Heart Failure NYHA Class III
Interventions
Barostim SystemDevice
Baroreflex Activation Therapy (BAT) using the Barostim System
Usual care medical managementOther
Usual care medical management alone - no device implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness EndpointTime frame: Through 24-months follow-up
- Primary Safety EndpointTime frame: Within 180 days of the device implant
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Cardiology Associates of Mobile
Mobile, Alabama · Recruiting
PIH Health Good Samaritan Hospital
Los Angeles, California · Recruiting
Keck School of Medicine of USC
Los Angeles, California · Recruiting
23 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.